Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Several recent reports have shown an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in those with psoriasis, which may reflect the increased occurrence of metabolic syndrome in this patient population.
the recruitment of 60 fatty live men with chronic disease, psoriasis, will be classified to lifestyle modification group (foe 12 weeks, this patients will take supervised energy or diet restriction program plus their usual immunosuppressive drugs ) and control group will continue their drug program only)
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intervention group | Experimental | The patients of this group will receive their usual immuno-modulating therapy plus life style modification (energy or diet restriction in addition to daily walking, 15000 steps) |
|
| control group | Active Comparator | The participants of this group will receive their usual immuno-modulating therapy and continuing their usual diet and activities |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| lifestyle modification | Other | for 12 week, the patients of this group will receive their usual immuno-modulating therapy plus life style modification (energy or diet restriction in addition to daily walking, 15000 steps) |
| Measure | Description | Time Frame |
|---|---|---|
| Psoriasis Area and Severity Index | it is an index used to measure level and severity of psoriasis | It will be measured after 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Dermatology Life Quality Index | it is a questinnaire used to assess life quality in psoriasis humans | It will be measured after 12 weeks |
| triglycerides | will measured in plasma |
Not provided
Inclusion Criteria:
Exclusion Criteria:
self-representation of gender identity
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali Ismail, lecturer | Contact | 02 01005154209 | allooka2012@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Ali Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of Physical Therapy Cairo University | Recruiting | Giza | Dokki | Egypt |
Not provided
| ID | Term |
|---|---|
| D011565 | Psoriasis |
| D005234 | Fatty Liver |
| ID | Term |
|---|---|
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D008107 | Liver Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| usual lifestyle | Other | the patients will receive the usual immuno-modulating therapy with continued usual diet and activities |
|
| It will be measured after 12 weeks |
| AST | it is plasma aspartate transaminase | It will be measured after 12 weeks |
| ALT | it is plasma Alanine transaminase | It will be measured after 12 weeks |
| BMI | it is body mass index | It will be measured after 12 weeks |
| waist circumference | it will be measured at the level of umbilicus | It will be measured after 12 weeks |
| D004066 | Digestive System Diseases |